Patent ID: 8497238

Claim:
A method of treating neurological disorders, of improving the function of nerve cells, or of improving the function of the nerve system in an individual comprising administering a nutraceutical or pharmaceutical composition including a) a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine or taurine; and c) a mineral fraction comprising at least one of manganese and molybdenum in an amount effective to treat neurological disorders, improve the function of nerve cells, or improve function of the nerve system, and wherein the composition provides per daily dose: d) at least one of DHA, DPA and EPA in a total amount of DHA, DPA and EPA taken together of about 400 to 3300 mg; e) a Uridine source which provides 0.08-3 g UMP; f) and wherein the composition provides per 100 kcal more than 2 ug molybdenum and more than 0.1 mg manganese.